FDA Adverse Event Injury Summary report: N

AJUST ADJUSTABLE SINGLE INCISION SLING

MDR report key: 3080429 · Received April 24, 2013

Report

Report Number
1018233-2013-01241
Event Type
Injury
Date Received
April 24, 2013
Report Date
March 25, 2013
Manufacturer
C.R. BARD, INC. (COVINGTON)
Product Code
FTL
PMA / PMN Number
K092607
Removal / Correction Number
NA
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
CO, US
Reporter Occupation
ATTORNEY

Narratives

Additional Manufacturer Narrative · 1

THE SAMPLE WAS NOT RETURNED. THE FINISHED PRODUCT MET ALL SPECS PRIOR TO BEING RELEASED FOR GENERAL DISTRIBUTION. THE INSTRUCTIONS FOR USE WHICH ACCOMPANIES ALL DEVICES CURRENTLY ADDRESSES POTENTIAL RISKS ASSOCIATED WITH SURGICALLY IMPLANTED MATERIALS. THE INSTRUCTIONS FOR USE STATES IN THE ADVERSE EVENTS: "COMPLICATIONS ASSOCIATED WITH THE PROPER IMPLANTATION OF THE AJUST SLING SYSTEM MAY INCLUDE, BUT ARE NOT LIMITED TO: POSTOPERATIVE HEMATOMA, ABSCESS OR FISTULA FORMATION WHICH MAY OCCUR FOLLOWING THE IMPLANT PROCEDURE. TEMPORARY URINARY RETENTION, BLADDER OUTLET OBSTRUCTION, AND VOIDING DIFFICULTIES ASSOCIATED WITH OVER-CORRECTION/TOO MUCH TENSION PLACED ON THE MESH SLING IMPLANT. PERFORATIONS OR LACERATIONS OF VESSELS, NERVES, BLADDER, OR ANY VISCERA, WHICH MAY OCCUR DURING INTRODUCER PASSAGE. IRRITATION AT THE OPERATIVE WOUND SITE WHICH MAY ELICIT A FOREIGN BODY RESPONSE THAT LEADS TO WOUND DEHISCENCE, INFLAMMATION OR EXTRUSION/EROSION OF THE IMPLANT. KNOWN RISKS OF ALL SURGICAL PROCEDURES FOR THE TREATMENT OF INCONTINENCE, WHICH MAY INCLUDE PAIN, DEVICE MIGRATION, AND FAILURE OF THE PROCEDURE RESULTING IN RECURRENCE OF INCONTINENCE." (B)(4).

Description of Event or Problem · 1

THE PT'S ATTORNEY ALLEGED A DEFICIENCY AGAINST THE DEVICE. ADD'L INFO HAS BEEN REQUESTED, BUT NOT YET RECEIVED. ASSOCIATED MDR: 1018233-2013-01322.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
175791 AJUST ADJUSTABLE SINGLE INCISION SLING FTL C.R. BARD, INC. (COVINGTON) NA CVTD0020

Patients

Seq Age Sex Outcome Treatment
1 63 YR Required Intervention